Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Malignant Neoplasms of Digestive Organs 1

Interventions

Specimen Handling 479pembrolizumab 454Magnetic Resonance Spectroscopy 421Carboplatin 327Cyclophosphamide 313Cisplatin 271Biopsy 270Radiotherapy 245Paclitaxel 230Gemcitabine 228Bevacizumab 211Nivolumab 188fludarabine 185venetoclax 174Drug Therapy 170Dexamethasone 158Blood Specimen Collection 158Oxaliplatin 155Injections 152Capecitabine 152Fluorouracil 144Docetaxel 142Standard of Care 135Radiosurgery 135Rituximab 125Pemetrexed 118durvalumab 115Leucovorin 108Radiation 107atezolizumab 105

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × gimeracil × 1 year × Clear all
NCT05934331 2025-09-12

A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

LaNova Medicines Limited

Phase 2 Recruiting
276 enrolled
Other neoplasm

Malignant Neoplasms of Digestive Organs

Data powered by HemOnc (CC BY 4.0) Colophon âš¡